ARTICLE | Clinical News
Burixafor: Phase I/II started
May 11, 2015 7:00 AM UTC
TaiGen began an open-label, dose-finding, Chinese Phase I/II trial to evaluate burixafor in combination with fludarabine and cytarabine chemotherapy in up to 15 patients. ...